Automotive, Healthcare Dec 03, 2021 07:59 AM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 3, Beijing Yiqiao Shenzhou announced yesterday that in order to support global scientific research and anti epidemic, after an emergency start of R & D, it completed a series of work from molecular construction to cell culture, protein purification and quality verification in only 6 days, and successfully produced Omicron mutant RBD protein reagent on December 1, And provide it to relevant institutions for research at the first time. At present, the protein reagent has been launched for global sales, and other protein and antibody reagents of Omicron mutant will be released one after another.
Related companies: